CLINICAL_TRIALS trial_result · 2017-10-24

Clinical Trial Update: A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus [Phase 3]

A Phase 3 trial comparing LY2963016 with LANTUS in adults with Type 2 diabetes mellitus has completed. Results were posted in October 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-10-24